Author:
Wiltgen Tun,Fleischmann Daniel F.,Kaiser Lena,Holzgreve Adrien,Corradini Stefanie,Landry Guillaume,Ingrisch Michael,Popp Ilinca,Grosu Anca L.,Unterrainer Marcus,Bartenstein Peter,Parodi Katia,Belka Claus,Albert Nathalie,Niyazi Maximilian,Riboldi Marco
Abstract
Abstract
Background
Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. 18F-Fluorethyltyrosine positron emission tomography (18F-FET PET) provides important diagnostic and grading information for brain tumors, but data on its use in survival prediction is scarce. In this study, we aim at investigating survival prediction based on multiple radiomic features in glioblastoma patients undergoing radio(chemo)therapy.
Methods
A dataset of 37 patients with glioblastoma (WHO grade 4) receiving radio(chemo)therapy was analyzed. Radiomic features were extracted from pre-treatment 18F-FET PET images, following intensity rebinning with a fixed bin width. Principal component analysis (PCA) was applied for variable selection, aiming at the identification of the most relevant features in survival prediction. Random forest classification and prediction algorithms were optimized on an initial set of 25 patients. Testing of the implemented algorithms was carried out in different scenarios, which included additional 12 patients whose images were acquired with a different scanner to check the reproducibility in prediction results.
Results
First order intensity variations and shape features were predominant in the selection of most important radiomic signatures for survival prediction in the available dataset. The major axis length of the 18F-FET-PET volume at tumor to background ratio (TBR) 1.4 and 1.6 correlated significantly with reduced probability of survival. Additional radiomic features were identified as potential survival predictors in the PTV region, showing 76% accuracy in independent testing for both classification and regression.
Conclusions
18F-FET PET prior to radiation provides relevant information for survival prediction in glioblastoma patients. Based on our preliminary analysis, radiomic features in the PTV can be considered a robust dataset for survival prediction.
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference38 articles.
1. Wirsching HG, Galanis E, Weller M. Glioblastoma. In: Berger MS, Weller M, editors. Handbook of clinical neurology, vol. 134. Amsterdam: Elsevier; 2016. p. 381–97.
2. Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev. 2017;18(1):3–9.
3. Tamimi AF, Juweid M. Epidemiology and outcome of glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma [internet]. Brisbane: Codon Publications; 2017. https://doi.org/10.15586/codon.glioblastoma.2017.ch8.
4. Fernandes C, Costa A, Osório L, et al. Current standards of care in glioblastoma therapy. In: De Vleeschouwer S, editor., et al., Glioblastoma [internet]. Brisbane: Codon Publications; 2017. https://doi.org/10.15586/codon.glioblastoma.2017.ch11.
5. Kocher M, Ruge MI, Galldiks N, Lohmann P. Applications of radiomics and machine learning for radiotherapy of malignant brain tumors. Strahlenther Onkol. 2020;196(10):856–67.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献